Last updated: 28 February 2024 at 5:12pm EST

Sally Susman Net Worth




The estimated Net Worth of Sally Susman is at least $25.5 Million dollars as of 23 February 2024. Ms. Susman owns over 63,837 units of Pfizer stock worth over $6,470,270 and over the last 20 years she sold PFE stock worth over $19,019,276. In addition, she makes $0 as Chief Corporate Affairs Officer and Executive Vice President at Pfizer.

Ms. Susman PFE stock SEC Form 4 insiders trading

Sally has made over 36 trades of the Pfizer stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 63,837 units of PFE stock worth $1,745,304 on 23 February 2024.

The largest trade she's ever made was exercising 130,875 units of Pfizer stock on 26 February 2014 worth over $1,662,113. On average, Sally trades about 27,758 units every 76 days since 2004. As of 23 February 2024 she still owns at least 218,148 units of Pfizer stock.

You can see the complete history of Ms. Susman stock trades at the bottom of the page.





Sally Susman biography

Sally Susman serves as Chief Corporate Affairs Officer, Executive Vice President of the Company. Executive Vice President, Corporate Affairs (formerly Policy, External Affairs and Communications) from December 2010 until December 2018. Senior Vice President, Policy, External Affairs and Communications from December 2009 until December 2010. Director of WPP plc.



How old is Sally Susman?

Sally Susman is 58, she's been the Chief Corporate Affairs Officer and Executive Vice President of Pfizer since 2019. There are 14 older and 14 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.

What's Sally Susman's mailing address?

Sally's mailing address filed with the SEC is 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK, NY, 10001-2192.

Insiders trading at Pfizer

Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read, and James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.



What does Pfizer do?

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.



Complete history of Ms. Susman stock trades at Estee Lauder Cos and Pfizer

Insider
Trans.
Transaction
Total value
Sally Susman
Executive Vice President
Option $1,745,304
23 Feb 2024
Sally Susman
Executive Vice President
Option $1,670,604
25 Feb 2023
Sally Susman
Executive Vice President
Option $2,294,217
22 Feb 2023
Sally Susman
Executive Vice President
Option $1,627,648
26 Feb 2022
Sally Susman
Executive Vice President
Option $2,102,309
23 Feb 2022
Sally Susman
Executive Vice President
Sale $2,415,672
26 Nov 2021
Sally Susman
Executive Vice President
Option $1,606,943
27 Feb 2021
Sally Susman
Executive Vice President
Option $1,869,358
25 Feb 2021
Sally Susman
Executive Vice President
Sale $1,831,184
9 Nov 2020
Sally Susman
Executive Vice President
Option $2,501,837
28 Feb 2020
Sally Susman
Executive Vice President
Option $2,506,530
26 Feb 2020
Sally Susman
Executive Vice President
Sale $2,760,874
4 Mar 2019
Sally Susman
Executive Vice President
Sale $377,444
4 Mar 2019
Sally Susman
Executive Vice President
Option $2,764,141
27 Feb 2019
Sally Susman
Executive Vice President
Option $2,055,409
23 Feb 2019
Sally Susman
Executive Vice President
Sale $1,502,981
20 Jul 2018
Sally Susman
Executive Vice President
Option $3,014,313
28 Feb 2018
Sally Susman
Executive Vice President
Sale $1,235,617
26 Feb 2018
Sally Susman
Executive Vice President
Option $1,736,456
24 Feb 2018
Sally Susman
Executive Vice President
Sale $1,338,050
12 Sep 2017
Sally Susman
Executive Vice President
Option $2,424,570
23 Feb 2017
Sally Susman
Executive Vice President
Option $2,424,570
23 Feb 2017
Sally Susman
Executive Vice President
Sale $2,288,370
9 May 2016
Sally Susman
Executive Vice President
Option $1,695,864
4 May 2016
Sally Susman
Executive Vice President
Option $2,097,541
24 Feb 2016
Sally Susman
Executive Vice President
Sale $1,570,086
12 Mar 2015
Sally Susman
Executive Vice President
Option $1,693,304
25 Feb 2015
Sally Susman
Executive Vice President
Sale $2,202,595
4 Mar 2014
Sally Susman
Executive Vice President
Option $1,662,113
26 Feb 2014
Sally Susman
Executive Vice President
Sale $1,496,403
6 Mar 2013
Sally Susman
Executive Vice President
Option $1,744,513
28 Feb 2013
Sally Susman
Sr. VP and Global Communications
Option $1,408,050
17 Apr 2007
Sally Susman
Sr. VP and Global Communications
Option $3,619,000
31 Jan 2007
Sally Susman
Sr. VP and Global Communications
Option $1,918,572
25 Oct 2006
Sally Susman
Sr. VP and Global Communications
Option $803,750
8 Feb 2006
Sally Susman
Sr. VP and Global Communications
Option $1,809,500
3 Dec 2004


Pfizer executives and stock owners

Pfizer executives and other stock owners filed with the SEC include: